Antibodies may provide 'silver bullet' for Ebola viruses
There may be a "silver bullet" for Ebola, a family of hemorrhagic viruses, one of which has killed more than 11,000 people in West Africa in the past two years.
View ArticleResearchers may hold key to developing a single treatment against several...
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc.
View ArticleEffects on HIV and Ebola
Cell culture experiments reveal potent antiviral activity of Cistus incanus.
View ArticleLab in a suitcase for real-time Ebola surveillance
A genomic surveillance system that can be packed into a suitcase and transported to the field to provide on-site Ebola virus genome sequencing, generating results within 24 hours of collecting...
View ArticleReal-time Ebola fusion system yields clues to stopping infection
Researchers have developed the first real-time system to watch directly through the microscope as Ebola-like virus particles fuse with human cells to infect them.
View ArticleResearchers present inner workings of Ebola vaccine trial
An experimental vaccine combined with an innovative way of vaccinating people has resulted in an estimated 100 percent efficacy of the vaccine against the Ebola virus in West Africa -- and the...
View ArticleNew nanotechnology detects biomarkers of cancer
Researchers at Wake Forest Baptist Medical Center have developed a new technology to detect disease biomarkers in the form of nucleic acids, the building blocks of all living organisms.
View ArticleToughen up, WHO: sanction outbreak dissenters
Changes to the World Health Organization's funding model, skill mix and engagement with emerging international health institutions such as Médicins Sans Frontières (MSF), will restore its...
View ArticleNew study highlights effectiveness of a herpesvirus cytomegalovirus-based...
A new study which represents a crucial step in the translation of herpesvirus-based Ebola virus vaccines into humans and other great apes.
View ArticleEbola crisis provides framework for responding to outbreaks like Zika virus
As world leaders grapple with containing the Zika virus, the Ebola epidemic in West Africa provides valuable lessons for how to respond to infectious disease epidemics, according to a policy report...
View ArticleResearchers discover new Ebola-fighting antibodies in blood of outbreak...
A research team that included scientists from The Scripps Research Institute (TSRI) has identified a new group of powerful antibodies to fight Ebola virus.
View ArticleA portable device for rapid and highly sensitive diagnostics
When remote regions with limited health facilities experience an epidemic, they need portable diagnostic equipment that functions outside the hospital.
View ArticleBat 'super immunity' could help protect people
For the first time researchers have uncovered a unique ability in bats which allows them to carry but remain unaffected by lethal diseases.Black-headed flying fox amongst a grey-headed colony.
View ArticleExperimental Ebola vaccines well tolerated, immunogenic in phase 2 study
Two investigational vaccines designed to protect against Ebola virus disease were well-tolerated and induced an immune response among 1,000 vaccinated participants in the Phase 2 randomized...
View ArticleEbola survivor study yields insights on complications of disease
Preliminary findings from PREVAIL III, a study of Ebola virus disease (EVD) survivors* being conducted in Liberia, indicate that both Ebola survivors and their close contacts have a high burden of...
View ArticleStudy: Experimental Ebola drug ZMapp may benefit patients, but insufficient...
According to initial results from a randomized, controlled trial of the experimental Ebola treatment ZMapp, the monoclonal antibody cocktail was well-tolerated and showed promise.
View ArticleProtective human-derived antibody against Ebola successfully isolated and...
The Institute for Research in Biomedicine (IRB), affiliated to the Università della Svizzera italiana (USI), and Humabs BioMed SA, a Swiss antibody therapeutics company, have identified, isolated...
View ArticleZeroing in on 'super spreaders' and other hidden patterns of epidemics
Ebola. Chikungunya. Zika. Once rare and exotic pathogens keep popping up and turning into household names.
View ArticleRisk of catching Ebola from survivor 'very low' if there is no sexual...
New research from the University of East Anglia shows that the risk of catching Ebola from a survivor is very low.
View ArticleNuanced findings for a large experimental treatment trial for Ebola virus...
While not conclusive, valuable research generated through researching an experimental treatment for Ebola virus disease in Guinea during the recent Ebola outbreak will support future research into...
View Article